Old Web
English
Sign In
Acemap
>
authorDetail
>
Camille L. Bedrosian
Camille L. Bedrosian
Medicine
Cancer research
Cancer
PI3K/AKT/mTOR pathway
Capecitabine
5
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical Benefit of Eculizumab in Patients with No Transfusion History in the International Paroxysmal Nocturnal Haemoglobinuria Registry
2017
Internal Medicine Journal
Antonio Almeida
Camille L. Bedrosian
Alexander Cole
Petra Muus
Hubert Schrezenmeier
Jeff Szer
Wendell F. Rosse
Show All
Source
Cite
Save
Citations (10)
Thérapie combinée à base de capécitabine
2007
Luca Gianni
Camille L. Bedrosian
Show All
Source
Cite
Save
Citations (0)
Veraibreichnung von mTor Inhibitoren
2006
Camille L. Bedrosian
Show All
Source
Cite
Save
Citations (0)
Administration d'un inhibiteur de mntor pour le traitement des patients atteints du cancer
2006
Camille L. Bedrosian
Show All
Source
Cite
Save
Citations (0)
Verabreichung von mntor-inhibitoren zur behandlung von krebspatienten
2006
Camille L. Bedrosian
Show All
Source
Cite
Save
Citations (0)
1